Cannara Biotech Inc. (LOVFF) Stock Overview
Explore Cannara Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.
Cannara Biotech Inc. (LOVFF)
Key Financials
Key Financials
Market Cap
113.6M
P/E Ratio
15.22
EPS (TTM)
$0.08
ROE
0.09%
LOVFF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cannara Biotech Inc. (LOVFF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 29.45, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $1.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.22 and a market capitalization of 113.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.